PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹367 Cr | ₹369 Cr | ₹656 Cr | ₹368 Cr | ₹407 Cr |
What is the latest Contingent Liabilities ratio of PANACEA BIOTEC ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹367 Cr |
| Mar2024 | ₹369 Cr |
| Mar2023 | ₹656 Cr |
| Mar2022 | ₹368 Cr |
| Mar2021 | ₹407 Cr |
How is Contingent Liabilities of PANACEA BIOTEC Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹367 Cr | -0.62 | |
| Mar2024 | ₹369 Cr | -43.67 | |
| Mar2023 | ₹656 Cr | 78.11 | |
| Mar2022 | ₹368 Cr | -9.54 | |
| Mar2021 | ₹407 Cr | - | |
Compare Contingent Liabilities of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,515.8 Cr | -0.7% | -8.2% | -1.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | -0.7% |
-8.2% |
-1.6% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses